Promising Pharmaceutical Stocks To Watch Now - July 9th

Verona Pharma PLC American Depositary Share, Eli Lilly and Company, and Evoke Pharma are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies involved in the research, development and manufacture of drugs, vaccines and other medical treatments. They offer investors exposure to the healthcare sector’s growth potential and dividends but also carry risks tied to regulatory approvals, patent expirations and the outcomes of clinical trials. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Verona Pharma PLC American Depositary Share (VRNA)

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis.

Shares of VRNA stock traded up $17.91 during trading hours on Wednesday, reaching $104.77. 57,573,365 shares of the stock traded hands, compared to its average volume of 1,486,074. The business has a fifty day moving average price of $81.95 and a 200 day moving average price of $66.58. The firm has a market capitalization of $8.92 billion, a PE ratio of -52.38 and a beta of 0.24. Verona Pharma PLC American Depositary Share has a 1-year low of $16.61 and a 1-year high of $104.98. The company has a quick ratio of 8.73, a current ratio of 8.86 and a debt-to-equity ratio of 1.07.

Read Our Latest Research Report on VRNA

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

LLY traded up $7.59 on Wednesday, reaching $785.25. 1,508,861 shares of the company traded hands, compared to its average volume of 3,658,863. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.37 and a quick ratio of 1.06. The company has a market cap of $744.22 billion, a price-to-earnings ratio of 63.91, a PEG ratio of 1.13 and a beta of 0.40. Eli Lilly and Company has a 52-week low of $677.09 and a 52-week high of $972.53. The stock's 50 day moving average price is $769.37 and its 200-day moving average price is $800.14.

Read Our Latest Research Report on LLY

Evoke Pharma (EVOK)

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.

Shares of EVOK stock traded up $4.81 during trading on Wednesday, reaching $7.47. The company had a trading volume of 127,949,490 shares, compared to its average volume of 641,068. Evoke Pharma has a one year low of $1.94 and a one year high of $12.32. The firm's 50 day simple moving average is $3.06 and its two-hundred day simple moving average is $3.56. The company has a market capitalization of $11.16 million, a PE ratio of -2.49 and a beta of -0.04.

Read Our Latest Research Report on EVOK